Mangoceuticals Ownership | Who Owns Mangoceuticals?


OverviewRevenueFinancialsChart

Mangoceuticals Ownership Summary


Mangoceuticals is owned by 8.21% institutional investors, 10.16% insiders, and 81.64% retail investors. Advisor group is the largest institutional shareholder, holding 0% of MGRX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.72% of its assets in Mangoceuticals shares.

MGRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMangoceuticals8.21%10.16%81.64%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryHealthcare Information Services Stocks 33.91%10.99%55.11%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Advisor group---
Jane street group---
Virtu financial---
Stonex group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Advisor group---
Jane street group---
Virtu financial---
Stonex group---

Top Buyers

HolderShares% AssetsChange
Advisor group---3.29K
Stonex group---16.04K
Virtu financial---61.03K
Jane street group---72.75K

Top Sellers

HolderShares% AssetsChange
Jane street group---72.75K
Virtu financial---61.03K
Stonex group---16.04K
Advisor group---3.29K

Sold Out

HolderChange
Advisor group-3.29K
Stonex group-16.04K
Virtu financial-61.03K
Jane street group-72.75K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202618-826,477-67.42%81.29%10-33.33%1-
Dec 31, 20251863.64%2,537,025577.34%25238.46%15114.29%1-
Sep 30, 20251110.00%374,55828.16%337.93%716.67%1-
Jun 30, 20251025.00%292,252288.03%2108.87%620.00%1-
Mar 31, 20258-11.11%75,317-17.54%120.71%5-44.44%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr123.04K0.72%-
Fidelity Extended Market Index76.53K0.45%-32.57K
NT Ext Equity Mkt Index Fund - NL18.96K0.11%-
Northern Trust Extended Eq Market Idx18.18K0.11%-
NT Ext Equity Mkt Index Fund - Lending18.18K0.11%-
Fidelity Series Total Market Index14.44K0.08%-
NT Ext Equity Mkt Idx Fd - DC - NL - T213.75K0.08%-1.10K
Fidelity Total Market Index12.61K0.07%-
Spartan Extended Market Index Pool F10.66K0.06%-
Spartan Total Market Index Pool A18.27K0.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 15, 2025JOHNSTON EUGENE M CFOSell$3.88K
Dec 09, 2025JOHNSTON EUGENE M CFOSell$5.97K
Dec 05, 2025JOHNSTON EUGENE M CFOSell$11.28K
Nov 19, 2025Hamilton Alex P.-Sell$152.88K
Jun 25, 2024Hamilton Alex P.-Sell$5.14K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

MGRX Ownership FAQ


Who Owns Mangoceuticals?

Mangoceuticals shareholders are primarily institutional investors at 8.21%, followed by 10.16% insiders and 81.63% retail investors. The average institutional ownership in Mangoceuticals's industry, Healthcare Information Services Stocks , is 33.91%, which Mangoceuticals falls below.

Who owns the most shares of Mangoceuticals?

Mangoceuticals’s largest shareholders are Advisor group (0 shares, 0%), Jane street group (0 shares, 0%), and Virtu financial (0 shares, 0%). Together, they hold 0% of Mangoceuticals’s total shares outstanding.

Does Blackrock own Mangoceuticals?

BlackRock is not among the top 10 institutional shareholders of Mangoceuticals.

Who is Mangoceuticals’s biggest shareholder by percentage of total assets invested?

Advisor group is Mangoceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Mangoceuticals shares, valued at 0$.

Who is the top mutual fund holder of Mangoceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Mangoceuticals shares, with 0.72% of its total shares outstanding invested in 123.04K Mangoceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools